National Cancer Research Institute South of England
Prostate Cancer Collaborative
Research

Epidermal Growth Factor And Voltage-Gated Sodium Channel : A Possible Secretory System Operating In Positive Feed-Back Mode To Accelerate Metastatic Prostate Cancer

 

Authors
Prof Mustafa Djamgoz
Imperial College London

The research overall is aimed at distinguishing aggressive from non-aggressive forms of human prostate cancer (PCa). We have shown previously that progression of rat and human PCa is accompanied by upregulation of specific voltage-gated Na + channel (VGSC) activity. This effect has also been observed in clinical human PCa specimens. A functional pathophysiological consequence of the upregulated VGSC activity is enhancement in vitro of a variety of cellular behaviours involved directly in the metastatic process. Such behaviours include cellular process extension, lateral motility, directional movement in small direct-current electric field, secretory membrane activity (endocytosis), adhesion, gene expression and transverse migration. However, the mechanism(s) responsible for the VGSC upregulation has not been clear. More recently, we have found that epidermal growth factor (EGF), which has been implicated in PCa progression, may control the VGSC upregulation. We now aim to evaluate a basic hypothesis which proposes that there is a positive feed-back interaction between EGF release and the VGSC upregulation that could be a significant factor accelerating PCa. This hypothesis will be tested by a complementary set of experiments involving assaying synthesis/release of EGF from human PCa (LNCaP, PC-3 and PC-3M) cell lines with differing metastatic potential and VGSC expression. We shall then determine the possible autocrine control of EGF release by VGSC activity.

 

Collaborative Home Page


Quick Links to other pages
grey = under construction

Aetiology and Genetics

Epidemiological Identification of Families
Genetic Susceptibility
Diet and Environment
Chemoprevention

Molecular Pathology

Links to Cancer Genome Project
Development of Normal Prostate
Microarray Expression Profiling
Candidate Genes
Novel Telomerase Suppressor Genes
Subtractive Hybridization
CESH

Novel Therapies

New Drugs for Prostate Cancer
Intensity Modulated Radiotherapy
Immunotherapy
Academic Urology Unit
Novel Targets from Cancer Genome Project
Novel Mechanism Based Drugs

Core Resources

Cancer Gene Cloning Lab
Prostate Tissue arrays
Microarray laboratory
Tissue and blood collections
Bioinformatics

Pilot and Development Funds

Tumor micro-environment in early prostate cancer

Collaborations
Meetings and Seminars

Contact us on Email: cbell@icr.ac.uk Tel: 0208 643 8901 Fax: 0208 770 7290 This page last modified: 4/06/03